Clinical Trial Update: Safety Study of Cancer Specific Epitope Peptides Cocktail for Cervical, GI, and Lung Tumors [Phase 1]

View source ↗

Summary

Phase 1 safety trial of a Cancer Specific Epitope Peptides Cocktail for cervical, gastrointestinal, and lung tumors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Cancer
• Gastrointestinal Cancer
• Lung Cancer

Drugs mentioned

• Cancer Specific Epitope Peptides Cocktail

Snippet

Sponsor: Kyushu University | Conditions: Metastatic Tumors | Phase 1 | Status: COMPLETED